IPN vs. IDPN: Choosing the Right Dialysis Nutrition Therapy

July 10, 2026

Malnutrition is one of the most consistent, and most under-treated, complications in patients with End Stage Renal Disease (ESRD). When dietary counseling and oral supplements are no longer enough, two specialized parenteral nutrition therapies can restore what dialysis takes away: Intraperitoneal Nutrition (IPN) and Intradialytic Parenteral Nutrition (IDPN).


They are often confused because both deliver nutrition through the patient’s existing dialysis access, without a separate IV line. But they are not interchangeable. The right choice comes down to one clinical fact: how the patient dialyzes.


Why Malnutrition Matters in ESRD


Protein-energy wasting (PEW) affects a large share of the dialysis population and is a strong predictor of hospitalization and mortality. It develops from a combination of poor appetite, chronic inflammation, metabolic acidosis, dietary restrictions, and, critically, protein losses that happen during dialysis itself.


That last point is why oral intake alone often can’t close the gap. When a patient is losing protein through the treatment, adding nutrition into the treatment is frequently the most effective intervention. This is where IPN and IDPN come in.


What Is IPN?


Intraperitoneal Nutrition (IPN) is for patients on peritoneal dialysis (PD). A sterile, individualized amino acid solution is substituted for one or more of the patient’s standard PD exchanges. Instead of a plain dextrose dialysate, the exchange delivers protein and nutrients directly across the peritoneal membrane, replacing what PD removes, during the same exchange the patient already performs.


Because IPN uses the existing peritoneal catheter, there are no additional needle sticks, no IV lines, and no changes to the patient’s PD schedule. It’s compatible with both CCPD (cycler) and CAPD (manual) regimens. Learn more about Pharmko’s Intraperitoneal Nutrition (IPN) therapy and how it’s compounded.


What Is IDPN?


Intradialytic Parenteral Nutrition (IDPN) is for patients on hemodialysis (HD). Amino acids, dextrose, and lipids are infused into the venous drip chamber of the hemodialysis circuit during the patient’s regular treatment, typically three times per week, delivering supplemental calories per session.


Like IPN, IDPN requires no separate access: it uses the dialysis circuit that’s already in place, and the infusion pump integrates into the treatment without adding IV poles or workflow burden. See Pharmko’s Intradialytic Parenteral Nutrition (IDPN) therapy for the full clinical process.



How to Choose: A Simple Clinical Framework


Selecting between the two therapies is rarely ambiguous, because the patient’s dialysis modality usually decides it. A practical way to think about it:


1. Start with the modality. Peritoneal dialysis → IPN. Hemodialysis → IDPN. This single question resolves most cases.


2. Confirm the nutritional indication. Both therapies are appropriate when a patient shows persistent malnutrition, commonly serum albumin below 3.5 g/dL, unintentional weight or muscle loss, or inadequate intake, despite first-line dietary counseling and oral nutritional supplements.


3. Confirm first-line measures were tried. IPN and IDPN are not first steps. Clinical guidelines support a stepwise approach: dietitian-led counseling, then renal-specific oral supplements, then parenteral nutrition when those are insufficient or not tolerated.


4. Rule out reversible causes. Neither therapy is a substitute for correcting underdialysis, inflammation, or acidosis. These should be optimized alongside nutrition therapy, not replaced by it.


What About TPN?


A third therapy, Total Parenteral Nutrition (TPN), is sometimes part of the conversation, but it addresses a different problem. TPN provides complete nutrition through a central venous catheter for patients whose GI tract can’t be used at all. IPN and IDPN are supplemental, targeted specifically at the nutrition dialysis removes. Most dialysis patients who can still eat, but can’t keep up, are candidates for IPN or IDPN rather than TPN.


The Pharmko Difference


Both IPN and IDPN are only as good as the formulation and the coordination behind them. Every Pharmko solution is compounded in our USP <797>-compliant, ISO Class 5 cleanroom, individualized to the patient’s labs, dialysis prescription, and nutritional status — never a standard premix. Our pharmacists work directly with nephrologists, renal dietitians, and PD/dialysis nurses, review labs on an ongoing basis, and adjust formulas as the patient’s needs change. We also handle prior authorizations and delivery logistics end to end.


Whether your patient dialyzes at home or at a center, the goal is the same: replace what dialysis removes, with as little burden on the patient as possible.


Ready to match a patient to the right therapy? Explore Pharmko’s dialysis and renal nutrition program or refer a patient today.


Refer a Patient  · [1 (877) 540-2003]


Renal dietitian reviewing albumin labs for a peritoneal dialysis patient
July 10, 2026
When to consider IPN for peritoneal dialysis patients with low albumin: clinical criteria, the stepwise nutrition approach, and the referral process.
How Home Infusion Reduces Hospital Readmissions
July 10, 2026
Home infusion therapy is associated with lower hospital readmission rates, fewer complications, and significant cost savings. Review the clinical evidence and learn how Pharmko supports discharge planning teams.
Primary Immune Deficiency and IVIG: A Guide for Newly Diagnosed Patients
July 8, 2026
Newly diagnosed with primary immune deficiency? Learn how IVIG therapy works, what to expect from your first infusions, how home IVIG is coordinated, and how Pharmko supports PID patients long-term.
Why They Matter and How Pharmko Customizes Your Formula
July 8, 2026
Trace minerals are essential components of every TPN formula. Learn what trace elements are included in parenteral nutrition, why each matters clinically, and how Pharmko pharmacists individualize your formula.
How to Choose a Home Infusion Pharmacy
June 26, 2026
Not all home infusion pharmacies are equal. Learn the 7 key questions to ask before choosing a specialty pharmacy, accreditation, clinical support, state licensing, and more.
Home Infusion for Lupus: Benlysta and Biologic Therapy Options for SLE
June 25, 2026
Learn how home infusion therapy works for lupus (SLE), including Benlysta (belimumab) and other IV biologics, who qualifies for home treatment, and how Pharmko supports ongoing lupus care across 22+ states.
IPN Therapy for Peritoneal Dialysis Patients
June 25, 2026
Learn how intraperitoneal nutrition (IPN) works for malnourished peritoneal dialysis patients, who qualifies, how amino acids are delivered during PD exchanges, and how Pharmko coordinates IPN therapy.
Home Infusion Therapy in New York
June 17, 2026
Pharmko is based in New York and provides home infusion therapy statewide — IV antibiotics, IVIG, TPN, IDPN, and specialty medications. Licensed, ACHC accredited, and available 24/7.
Home Infusion for Osteomyelitis
June 15, 2026
Osteomyelitis requires weeks of IV antibiotics that can often be completed at home. Learn who qualifies for OPAT, what the treatment timeline looks like, and how Pharmko supports bone infection recovery.
What Is a PICC Line
June 15, 2026
Learn what a PICC line is, how it's inserted, how to care for it at home, and why it's the most common IV access device for home infusion therapy. Pharmko nurses provide full PICC line training.
Show More